To further investigate the effect of GSK on hepatic TFEB nuclear translocation and metabolic homeostasis in established NAFLD model, we fed mice WD for 10 weeks and treated mice with GSK for 2 weeks. This evidence concerns the gene TFEB and metabolic dysfunction-associated steatotic liver disease.